Millennium Management’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Millennium Management’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,207	Closed	-$8.81K	–	6721
2023 Q2	$8.81K	Sell	1,207 -1,873	-61%	-$16.5K	﹤0.01%	5782
2023 Q1	$30K	Buy	+3,080	New	+$23.8K	﹤0.01%	5770
2021 Q1	–	Sell	-1,083	Closed	-$106K	–	6619
2020 Q4	$106K	Sell	1,083 -451	-29%	-$35.2K	﹤0.01%	5012
2020 Q3	$96	Hold	1,534	–	–	﹤0.01%	4226
2020 Q2	$129K	Hold	1,534	–	–	﹤0.01%	3940
2020 Q1	$82K	Hold	1,534	–	–	﹤0.01%	3591
2019 Q4	$112K	Sell	1,534 -224	-13%	-$10.8K	﹤0.01%	4011
2019 Q3	$78K	Sell	1,758 -200	-10%	-$11.4K	﹤0.01%	3996
2019 Q2	$140K	Sell	1,958 -310	-14%	-$22.8K	﹤0.01%	3840
2019 Q1	$172K	Sell	2,268 -100	-4%	-$8.34K	﹤0.01%	3771
2018 Q4	$157K	Sell	2,368 -1,057	-31%	-$78.3K	﹤0.01%	3460
2018 Q3	$299K	Sell	3,425 -420	-11%	-$43.8K	﹤0.01%	3483
2018 Q2	$444K	Sell	3,845 -318	-8%	-$59.8K	﹤0.01%	3217
2018 Q1	$874K	Sell	4,163 -194	-4%	-$41.3K	﹤0.01%	2763
2017 Q4	$959K	Buy	+4,357	New	+$1.03M	﹤0.01%	2725

Other funds holding PHXM

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's PHXM Position: Q3 2023 in Review

Millennium Management sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2023, closing a stake of 1,207 shares — an estimated $8.81K sold.

Millennium Management first reported a position in PHXM in Q4 2017 and held it in 15 quarters. The position peaked at $959K in Q4 2017. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2023.

Millennium Management reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 1,207 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2023, an estimated $8.81K.
Millennium Management first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 15 quarters.
Millennium Management's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $959K in Q4 2017.
3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.